NeuroSense Therapeutics Ltd. Cash Flows From Used In Investing Activities
NeuroSense Therapeutics Ltd. (NRSN) reported Cash Flows From Used In Investing Activities of $3.65 million for the 12-month period ending 2023-12-31, per its 20-F filed 2024-04-04.
Discontinued › Cash Flow › Investing Activities
ifrs-full:CashFlowsFromUsedInInvestingActivities · last filed 2024-04-04
| Period end | Cash Flows From Used In Investing Activities 6 month | Cash Flows From Used In Investing Activities 12 month |
|---|---|---|
| 2023-12-31 | $3.65M 20-F · filed 2024-04-04 | |
| 2023-06-30 | $3.52M 6-K · filed 2023-08-16 | |
| 2022-12-31 | -$3.54M 20-F · filed 2024-04-04 | |
| 2022-06-30 | -$6.05M 6-K · filed 2023-08-16 | |
| 2021-12-31 | -$17.00K 20-F · filed 2024-04-04 | |
| 2021-06-30 | -$2.00K 6-K/A · filed 2023-01-19 | |
| 2020-12-31 | -$9.00K 20-F · filed 2023-03-22 | |
| 2019-12-31 | -$26.00K 20-F · filed 2022-04-14 |